Supplementary Data
Removal of trimethylamine (fishy odor) by C3 and CAM plants
Phattara Boraphech, Paitip Thiravetyan
School of Bioresources and Technology, King Mongkut’s University of Technology Thonburi, Bangkok 10150, Thailand
Table 4S Summarize metabolic compounds found in leaves and roots of S. trifasciata under non-treatment (control) and TMA treatment conditionsMetabolic compounds / %
Similarity / %
of total / Metabolic compounds / %
Similarity / %
of total
12 h : Control (non-treatment) / 12 h of TMA Treatment
Leaves / Leaves
3-Methyl-2,5-furandione / 91 / 54.0 / 3-Methyl-2,5-furandione / 91 / 21.5
3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 90 / 14.9 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 90 / 7.6
2,3-Dihydro-1-benzofuran / 90 / 19.0 / 2,3-Dihydro-1-benzofuran / 83 / 7.7
n-Hexadecanoic acid / 91 / 12.2 / 2-Betenoic acid / 78 / 9.5
2-Furancarboxaldehyde / 86 / 13.1
(Z)-9-Octadecenamide / 98 / 16.4
n-Hexadecanoic acid / 91 / 0.8
2-Propanone / 74 / 6.6
Ethylamine / 47 / 0.7
3-Methyl-2-butanamine / 82 / 2.8
2-Amino-2-oxo-acetic acid / 64 / 2.1
1H-Imidazole-5-carboxamide / 53 / 1.4
Butanamide / 64 / 2.0
Hexadecanamide / 86 / 1.8
5-Methyl-2,4(1H,3H)-pyrimidinedione (Thymine) / 53 / 5.9
Roots / Roots
3-Methyl-2,5-furandione / 81 / 37.7 / 1,3-Dihydroxyacetone / 78 / 13.9
3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 90 / 15.8 / 3-Methyl-2,5-furandione / 87 / 7.1
4-Vinylphenol / 80 / 8.3 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 87 / 4.9
2-Furancarboxaldehyde / 95 / 32.0 / 4-Vinylphenol / 94 / 1.4
n-Hexadecanoic acid / 95 / 6.1 / 2-Furancarboxaldehyde / 95 / 4.3
n-Hexadecanoic acid / 99 / 3.9
1,3-O-Methylenepentitol / 60 / 6.6
Tetrahydro-2H-pyran-4-ol / 53 / 0.8
Octadecanoic acid / 97 / 2.4
Ethylamine / 87 / 0.7
N-acetylalanine / 73 / 1.9
3-Methylquinoline / 89 / 1.7
2-Amino-3-hydroxybenzoic acid / 55 / 1.0
guanine / 53 / 34.7
Cytidine / 50 / 14.7
24 h : Control (non-treatment) / 24 h of TMA Treatment
Leaves / Leaves
3-Methyl-2,5-furandione / 91 / 16.2 / 3-Methyl-2,5-furandione / 91 / 13.7
4-Vinylphenol / 90 / 3.6 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 91 / 2.4
2-Betenoic acid / 70 / 9.5 / 2,3-Dihydro-1-benzofuran / 90 / 3.7
(Z)-9-Octadecenamide / 99 / 70.7 / 2-Betenoic acid / 58 / 2.6
2-Furancarboxaldehyde / 60 / 15.6
(Z)-9-Octadecenamide / 99 / 18.6
n-Hexadecanoic acid / 81 / 0.8
Glyceraldehyde / 53 / 1.2
Dihydroxyacetone / 78 / 10.8
Tetrahydro-2H-pyran-2-ol / 58 / 0.9
2-Furylmethanol / 78 / 1.5
Methylamine / 98 / 20.1
Ethylamine / 58 / 0.6
3,3-Dimethylbutylamine / 53 / 1.0
Pentanamide / 72 / 0.2
Hexadecanamide / 90 / 0.2
2-Formylhistamine / 83 / 3.8
Cytidine / 50 / 2.0
Roots / Roots
3-Methyl-2,5-furandione / 91 / 11.1 / 1,3-Dihydroxyacetone / 99 / 2.7
Benzoic acids / 59 / 10.0 / 3-Methyl-2,5-furandione / 87 / 7.7
2-Furancarboxaldehyde / 91 / 2.7 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 81 / 8.4
(Z)-9-Octadecenamide / 99 / 55.1 / 4-Vinylphenol / 64 / 1.8
2H-Pyran-3(6H)-one / 53 / 12.5 / 2-Furancarboxaldehyde / 93 / 9.5
Hexadecanamide / 90 / 8.6 / n-Hexadecanoic acid / 93 / 0.9
(Z)-9-Octadecenamide / 98 / 18.7
Formaldehyde / 87 / 14.0
Glyceraldehyde / 64 / 3.5
2,3-Dihydro-1-benzofuran / 68 / 1.1
Ethane / 93 / 7.4
Dimethylamine / 94 / 7.4
Ethylamine / 79 / 0.5
1,1-Dimethylhydrazine / 89 / 2.3
2-Nitro-1,4-benzenediamine / 91 / 1.1
Tetradecanamide / 86 / 2.7
2,3-Dihydroxanthosine / 89 / 3.5
guanine / 88 / 7.0
36 h : Control (non-treatment) / 36 h of TMA Treatment
Leaves / Leaves
3-Methyl-2,5-furandione / 91 / 38.9 / 3-Methyl-2,5-furandione / 91 / 5.3
4-Vinylphenol / 78 / 10.7 / 2,3-Dihydro-1-benzofuran / 80 / 2.4
2-Furancarboxaldehyde / 60 / 34.4 / 2-Betenoic acid / 95 / 2.6
Butanoic acid / 87 / 16.0 / 1-Amino-2-propanol / 89 / 7.6
N-(4-Nitrophenyl)-L-alaninamide / 96 / 0.8
Guanine / 93 / 14.7
Cytidine / 93 / 66.7
Roots / Roots
1,3-Dihydroxyacetone / 64 / 32.6 / 1,2-Dihydropyrimidine / 89 / 15.9
3-Methyl-2,5-furandione / 76 / 14.1 / 2-phenyl-n-methylindole / 91 / 84.1
Benzoic acids / 47 / 17.9
3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 87 / 10.4
4-Vinylphenol / 59 / 2.5
2-Furancarboxaldehyde / 70 / 9.1
n-Hexadecanoic acid / 96 / 4.2
Malonic acid / 38 / 4.3
2-Methoxy-4-vinylphenol / 91 / 2.7
Phenol / 41 / 2.4
48 h : Control (non-treatment) / 48 h of TMA Treatment
Leaves / Leaves
3-Methyl-2,5-furandione / 93 / 80.0 / 3-Methyl-2,5-furandione / 91 / 22.9
2,3-Dihydro-1-benzofuran / 81 / 20.0 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 87 / 8.6
4-Vinylphenol / 90 / 9.0
2-Furancarboxaldehyde / 84 / 14.9
n-Hexadecanoic acid / 95 / 1.6
Dihydroxyacetone / 99 / 2.7
2-Furylmethanol / 90 / 2.0
2-Octylguanidine / 97 / 26.1
Guanine / 80 / 12.2
Roots / Roots
1,3-Dihydroxyacetone / 72 / 14.6 / 1,3-Dihydroxyacetone / 64 / 12.2
3-Methyl-2,5-furandione / 87 / 40.2 / 3-Methyl-2,5-furandione / 91 / 8.5
3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 91 / 17.4 / Benzoic acids / 59 / 16.6
4-Vinylphenol / 72 / 5.3 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 93 / 4.2
2-Furancarboxaldehyde / 91 / 16.2 / 4-Vinylphenol / 72 / 1.2
n-Hexadecanoic acid / 92 / 4.7 / 2-Furancarboxaldehyde / 92 / 5.4
4-methylbenzaldehyde / 58 / 1.6 / n-Hexadecanoic acid / 95 / 2.0
Glyceraldehyde / 89 / 2.2
Methylamine / 97 / 1.9
Dimethylamine / 88 / 2.1
guanine / 84 / 43.7
Table 5S Summarize metabolic compounds found in stems of P. indicus under non-treatment (control) and TMA treatment conditions
Metabolic compounds / % Similarity / %
of total / Metabolic compounds / % Similarity / %
of total
24 h : Control (non-treatment) / 24 h of TMA treatment
2-Cyclohexen-1-one / 91 / 3.0 / 2-Cyclohexen-1-one / 91 / 0.8
2-Methoxy-4-vinylphenol / 90 / 4.0 / 2-Methoxy-4-vinylphenol / 87 / 3.2
(Z)-9-Octadecenamide / 99 / 16.1 / (Z)-9-Octadecenamide / 93 / 8.8
Benzofuran / 87 / 5.5 / Benzofuran / 87 / 3.2
2-Ethylacridine / 97 / 0.2 / 3-Methylenedihydro-2,5-furandione / 87 / 2.7
3-Methylenedihydro-2,5-furandione / 91 / 5.0 / [2,7]Naphthyridine-1,3,6,8-tetraol / 91 / 4.9
Octadecanamide / 87 / 2.2 / N-methyl-1-Octadecanamine / 96 / 4.9
Tetradecanamide / 89 / 2.9 / 3-Methyl-3,5-(cyanoethyl)tetrahydro-4-thiopyranone / 85 / 14.2
11-Tricosene / 95 / 2.8 / 7-Nonenamide / 72 / 2.0
2-Butenoic acid / 87 / 43.1 / 3,3-dimethyl-4-(1-aminoethyl)-Azetidin-2-one / 99 / 1.6
2-Nonenoic acid / 92 / 1.9 / Cyclohexane / 79 / 0.4
Benzeneacetaldehyde / 87 / 0.5 / Benzofurazan / 87 / 12.2
Butanal, dimethylhydrazone / 53 / 0.9 / Hexadecanoic acid / 92 / 10.4
Cycloserine / 88 / 1.9 / N-Isopropyl-3-phenylpropanamide / 89 / 0.6
Formic acid / 98 / 0.5 / Nonadecanamide / 78 / 10.1
n-Hexadecanoic acid / 95 / 8.3 / 2-ethyltetrahydrothiophene / 88 / 20.1
Z-10-Octadecen-1-ol acetate / 81 / 1.2
48 h : Control (non-treatment) / 48 h of TMA treatment
2-Cyclohexen-1-one / 91 / 33.5 / 2-Cyclohexen-1-one / 91 / 1.6
3-Methylenedihydro-2,5-furandione / 53 / 6.9 / 2-Methoxy-4-vinylphenol / 91 / 7.4
1-Methyl-cyclopentanol / 60 / 6.7 / (Z)-9-Octadecenamide / 96 / 13.2
Benzeneacetaldehyde / 92 / 11.2 / Benzofuran / 87 / 5.9
Dodecylcyclohexane / 94 / 5.4 / Tetradecanamide / 80 / 23.8
Hexadecanamide / 87 / 20.1 / Dimethylamine / 99 / 4.3
(Z)-9-Octadecenamide / 91 / 16.4 / 3,5-Dihydroxy-6-methyl-2,3-dihydro-4H-pyran-4-one / 84 / 0.1
4-Methyl-1,3-oxazole-5-carboxamide / 95 / 1.1
Acridine / 86 / 0.5
Ethane / 95 / 0.1
l-4-Hydroxy-1-methylproline / 59 / 31.3
Propanal, dimethylhydrazone / 96 / 10.7
72 h : Control (non-treatment) / 72 h of TMA treatment
2-Cyclohexen-1-one / 91 / 6.2 / 2-Cyclohexen-1-one / 91 / 0.8
3-Methylenedihydro-2,5-furandione / 83 / 3.5 / 2-Methoxy-4-vinylphenol / 95 / 2.8
1-Methyl-cyclopentanol / 52 / 2.5 / (Z)-9-Octadecenamide / 98 / 23.5
2-methyl-6-Hepten-1-ol / 96 / 3.5 / Benzofuran / 78 / 2.8
Dodecylcyclohexane / 91 / 3.8 / 2-Ethylacridine / 87 / 6.4
Hexadecanamide / 90 / 23.7 / Tetradecanamide / 80 / 10.0
(Z)-9-Octadecenamide / 99 / 56.8 / Dimethylamine / 92 / 0.1
n-Hexadecanoic acid / 97 / 1.8
2-Formylhistamine / 88 / 0.5
2-Propenoic acid / 86 / 4.5
4-Hydroxy-2-methylproline / 98 / 10.3
Cyclotetradecane / 76 / 16.7
Dodecahydropyrido[1,2-b]isoquinolin-6-one / 42 / 2.2
Ethylamine / 99 / 0.4
Hexadecanamide / 91 / 16.2
N-(2-Acetylcyclopentylidene)cyclohexylamine / 87 / 1.2
1 of 3
Corresponding author; Tel. 66-2-470-7535, Fax: 66-2-452-3455.
E-mail address: (P. Thiravetyan).